The incidence of VEGF-C and VEGF-D detected in ovarian carcinomas was significantly higher than that detected in benign tumours (Table 1, P<0.0001, respectively) and borderline tumours (Table 1, P=0.0002 and 0.0007, respectively). This evidence concerns the gene VEGFC and benign neoplasm.